DermAb.io Israeli Company

DermAb.io is developing a proprietary assay for prescribing personalized biologic therapies. The company's noninvasive technology retrieves biomarkers painlessly from the skin’s surface in less than one minute. DermAb.io's machine learning-based model provides the predictive value for physicians to prescribe the most effective biological medication right away.